Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis)

Annals of the New York Academy of Sciences

Volumn 1111, Issue , 2007, Pages 290-300

  Johnson, Suzanne M ^a   Lerche, Nicholas W ^b   Pappagianis, Demosthenes ^a   Yee, Joann L ^b   Galgiani, John N ^c   Hector, Richard F ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coccidioides; Coccidioidomycosis; Experimental model; Immunity; Infection; Primate; Vaccine

Indexed keywords

CHIMERIC FUSION PROTEIN; GAMMA INTERFERON; RECOMBINANT AG2/PR 106; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGENICITY; AUTOPSY; BRONCHOALVEOLAR LAVAGEMONONUCLEAR CELLS; COCCIDIOIDES; COCCIDIOIDES POSADASII; COCCIDIOIDOMYCOSIS; COMPLEMENT FIXATION; CONFERENCE PAPER; CONTROLLED STUDY; CYNOMOLGUS MACAQUES; DRUG EFFICACY; DRUG SAFETY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MACACA; NONHUMAN; SENSITIZATION;

ANIMALIA; COCCIDIOIDES; COCCIDIOIDES POSADASII; MACACA; MACACA FASCICULARIS; PRIMATES;

EID: 35348850079     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1406.042     Document Type: Conference Paper

References (20)

1. VALDIVIA, L. et al. 2006. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg. Infect. Dis. 12: 958-962.
2. ZHU, Y. et al. 1996. Coccidioides immitis Antigen 2: analysis of gene and protein. Gene 181: 121-125.
3. ZHU, Y.et al.1996. Molecular cloning and characterization of Coccidioides immitis Antigen 2 cDNA. Infect. Immun. 64: 2695-2696.
4. DUGGER, K.O. et al. 1996. Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential. Biochem. Biophys. Res. Commun. 218: 485-489.
5. DUGGER, K.O. et al. 1991. An immunoreactive apoglycoprotein purified from Coccidioides immitis. Infect. Immun. 59: 2245-2241.
6. KIRKLAND, T.N. et al. 1998. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect. Immun. 66: 3519-3922.
7. SHUBITZ, L.F. et al. 2002. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant Antigen 2/PRA. Infect. Immun. 70: 3287-3289.
8. JIANG, C. et al. 1999. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant Antigen 2 and Antigen 2 cDNA. Infect. Immun. 67: 630-635.
9. ABUODEH, R.O. et al. 1999. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or DNA vaccine of a proline-rich antigen. Infect. Immun. 67: 2935-2940.
10. SHUBITZ, L.F. et al. 2006. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein. Vaccine 24: 5904-5911.
11. COX, R.A. & D.M. MAGEE. 2004. Coccidioidomycosis: host response and vaccine development. Clin. Microbiol. Rev. 17: 804-839.
12. LEVINE, H.B., R.L. MILLER & C.E. SMITH. 1962. Influence of vaccination on respiratory coccidioidal disease in cynomologous monkey. J. Immun. 89: 242-251.
13. SMITH, C.E., M.T. SAITO & S.A. SIMONS. 1956. Pattern of 39,000 serologic tests in coccidioidomycosis. J. Am. Med. Assoc. 160: 546-552.
14. SMITH, C.E. et al. 1950. Serological tests in the diagnosis of coccidioidomycosis. Am. J. Hyg. 52: 1-21.
15. WEGNER, T.N. et al. 1972. Some evidence for the development of a phagocytic response by polymorphonuclear leukocytes recovered from the venous blood of dogs inoculated with Coccidioides immitis or vaccinated with irradiated spherule vaccine. Am. Rev. Resp. Dis. 105: 845-849.
16. PAPPAGIANIS, D. & B.L. ZIMMER. 1990. Serology of coccidioidomycosis. Clin. Microbiol. Rev. 3: 247-268.
17. CLEMONS, K.V., C.R. LEATHERS & K.W. LEE. 1985. Systemic Coccidioides immitis infection in nude and beige mice. Infect. Immun. 47: 814-821.
18. MAGEE, D.M. & R.A. COX. 1985. Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect. Immun. 63: 3519-3519.
19. KLINMAN, D.M. et al. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. 93: 2879-2883.
20. KUMAR, S. et al. 2004. CpG oligodeoxynucleotide and montanide ISA 51 adjuvant combination enhance the protective efficacy of a subunit malaria vaccine. Infect. Immun. 72: 949-957.